ASP Isotopes Inc. (NASDAQ:ASPI) Stake Lessened by GSA Capital Partners LLP

GSA Capital Partners LLP lowered its holdings in ASP Isotopes Inc. (NASDAQ:ASPI) by 25.0% in the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 254,823 shares of the company’s stock after selling 84,900 shares during the period. GSA Capital Partners LLP owned approximately 0.52% of ASP Isotopes worth $1,052,000 as of its most recent SEC filing.

Separately, HTLF Bank purchased a new stake in shares of ASP Isotopes in the fourth quarter valued at $141,000. 16.80% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Separately, HC Wainwright upped their price target on shares of ASP Isotopes from $5.25 to $5.50 and gave the stock a “buy” rating in a research note on Wednesday, April 17th.

Insiders Place Their Bets

In other ASP Isotopes news, Director Robert John Andrew Ryan bought 9,500 shares of the stock in a transaction on Thursday, April 25th. The shares were purchased at an average cost of $3.42 per share, with a total value of $32,490.00. Following the completion of the transaction, the director now directly owns 546,555 shares of the company’s stock, valued at approximately $1,869,218.10. The purchase was disclosed in a filing with the SEC, which is accessible through the SEC website. Company insiders own 26.30% of the company’s stock.

ASP Isotopes Stock Up 11.4 %

Shares of NASDAQ ASPI traded up $0.35 during mid-day trading on Wednesday, reaching $3.43. The company had a trading volume of 701,360 shares, compared to its average volume of 735,755. The company has a debt-to-equity ratio of 1.70, a quick ratio of 3.57 and a current ratio of 3.57. The stock has a market capitalization of $177.54 million, a PE ratio of -6.17 and a beta of 5.12. ASP Isotopes Inc. has a twelve month low of $0.57 and a twelve month high of $5.67. The stock’s 50 day moving average is $3.97 and its 200-day moving average is $3.39.

ASP Isotopes (NASDAQ:ASPI) last posted its earnings results on Wednesday, May 15th. The company reported ($0.16) EPS for the quarter. The business had revenue of $0.84 million for the quarter. As a group, equities analysts anticipate that ASP Isotopes Inc. will post -0.11 earnings per share for the current fiscal year.

About ASP Isotopes

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235.